Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
JNJ | NYSE | USD | Real-time | |
JNJ | Mexico | MXN | Delayed | |
1JNJ | Milan | EUR | Real-time | |
JNJ | TradeGate | EUR | Delayed | |
JNJ | Xetra | EUR | Delayed | |
JNJ | Frankfurt | EUR | Delayed | |
DJNJ2m | Buenos Aires | ARS | Delayed | |
JNJm | Buenos Aires | ARS | Delayed | |
JNJB34 | B3 | BRL | Delayed | |
JNJ | Vienna | EUR | Real-time | |
JNJ | Ukraine | UAH | Delayed | |
JNJ_KZ | KASE | USD | Delayed | |
JNJ_KZTQKD | KASE | USD | Delayed | |
JNJ | Colombia | COP | Delayed | |
JNJ | Lima | USD | Delayed |
Johnson & Johnson reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 21,383 million compared to USD 20,894 million a year ago. Net income was USD 5,354 million compared to net loss of USD 68 million a year ago. Basic earnings per share from continuing operations was USD 2.2 compared to basic loss per share from continuing operations of USD 0.19 a year ago. Diluted earnings per share from continuing operations was USD 2.2 compared to diluted loss per share from continuing operations of USD 0.19 a year ago.
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Oct 01, 2023 | Jul 02, 2023 |
---|---|---|---|---|
Total Revenue | 21383 | 21395 | 21351 | 25530 |
Gross Profit | 14879 | 14680 | 14971 | 17518 |
Operating Income | 6310 | 4730 | 6421 | 7382 |
Net Income | 3255 | 4049 | 26028 | 5144 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Oct 01, 2023 | Jul 02, 2023 |
---|---|---|---|---|
Total Assets | 171966 | 167558 | 166061 | 191686 |
Total Liabilities | 101946 | 98784 | 94833 | 115277 |
Total Equity | 70020 | 68774 | 71228 | 76409 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Oct 01, 2023 | Jul 02, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | 3657 | 7863 | 4182 | |
Cash From Investing Activities | -464 | -1202 | -3776 | |
Cash From Financing Activities | 546 | -4655 | -5991 | |
Net Change in Cash | 3614 | 2131 | -5682 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review